MedTech Contract Manufacturing Organization (CMO) Market Introduction and Overview
According to SPER Market Research, the Global MedTech Contract Manufacturing Organization (CMO) Market is estimated to reach USD 339.2 billion by 2034 with a CAGR of 8.21%.
The market is expected to rise as a result of improvements in biopharmaceutical manufacturing technology, increased attention to gene treatments and personalized medicine, and new opportunities for Contract Manufacturing Organizations (CMO). Additionally, as the demand for generic drugs rises, more healthcare organizations are outsourcing their manufacture to CMOs in an effort to save costs and increase efficiency. It is projected that this will support market expansion in the upcoming years. However, the market for MedTech CMOs faces many obstacles, such as cost considerations and strict regulatory compliance. Although following regulations like as GMP, ISO certification, and FDA criteria is essential, it is also difficult and resource-intensive. CMOs are also responsible for sourcing raw materials, controlling production costs, and raising product quality while upholding strict requirements.
- Lonza and Acumen Pharmaceuticals, Inc. partnered in April 2024 to produce Sabirnetug (ACU193), the first monoclonal antibody used to treat Alzheimer's disease.
- In June 2023, Vetter Pharma-Fertigung GmbH & Co. KG declared its intention to increase its U.S. manufacturing capacity in order to satisfy the growing demands of its clientele.
By Service: The market is divided into segments based on service: API manufacturing, finished products, and packaging. The finished product segment is further categorized into solid dosage forms, injectables, and others. In 2023, the API manufacturing segment held the largest share of the global Contract Manufacturing Organizations (CMO) market. This growth is primarily driven by the increasing trend among global pharmaceutical companies to outsource API production to specialized CMOs. This approach offers various advantages, including cost-effective solutions, particularly in emerging countries. Additionally, the rising global exports of APIs are expected to boost manufacturing demand, creating significant opportunities for CMOs and contributing to the growth of this segment.
By Region: North America dominated the market in 2023, bringing in USD 47.3 billion. The growing need for economical and efficient drug production methods, especially for safer and more potent medications like biologics and advanced therapies, is what is causing this expansion. As a result, Contract Manufacturing Organizations (CMOs) are increasingly being used to produce these medications, which is predicted to further boost the region's market expansion.
Market Competitive Landscape
The Global MedTech Contract Manufacturing Organization (CMO) Market is highly consolidated. Some of the market players are Almac Group, Boehringer Ingelheim International GmbH, Catalent, Inc., Dr. Reddy’s Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharmova Limited, Lonza, Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Service.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Almac Group, Boehringer Ingelheim International GmbH, Catalent, Inc., Dr. Reddy’s Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharmova Limited, Lonza, Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Others. |
Key Topics Covered in the Report:
- Global MedTech Contract Manufacturing Organization (CMO) Market Size (FY’2025-FY’2034)
- Overview of Global MedTech Contract Manufacturing Organization (CMO) Market
- Segmentation of Global MedTech Contract Manufacturing Organization (CMO) Market By Service (API, Manufacturing, Finished Product, Packaging)
- Statistical Snap of Global MedTech Contract Manufacturing Organization (CMO) Market
- Expansion Analysis of Global MedTech Contract Manufacturing Organization (CMO) Market
- Problems and Obstacles in Global MedTech Contract Manufacturing Organization (CMO) Market
- Competitive Landscape in the Global MedTech Contract Manufacturing Organization (CMO) Market
- Details on Current Investment in Global MedTech Contract Manufacturing Organization (CMO) Market
- Competitive Analysis of Global MedTech Contract Manufacturing Organization (CMO) Market
- Prominent Players in the Global MedTech Contract Manufacturing Organization (CMO) Market
- SWOT Analysis of Global MedTech Contract Manufacturing Organization (CMO) Market
- Global MedTech Contract Manufacturing Organization (CMO) Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global MedTech Contract Manufacturing Organization (CMO) Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global MedTech Contract Manufacturing Organization (CMO) Market
7. Global MedTech Contract Manufacturing Organization (CMO) Market, By Service (USD Million) 2025-2034
7.1. API
7.2. Manufacturing
7.3. Finished Product
7.3.1. Solid Dosage Forms
7.3.2. Injectables
7.3.3. Others
7.4. Packaging
8. Global MedTech Contract Manufacturing Organization (CMO) Market, By Region, 2025-2034 (USD Million)
8.1. Asia-Pacific
8.1.1. Australia
8.1.2. China
8.1.3. India
8.1.4. Japan
8.1.5. South Korea
8.1.6. Rest of Asia-Pacific
8.2. Europe
8.2.1. France
8.2.2. Germany
8.2.3. Italy
8.2.4. Spain
8.2.5. United Kingdom
8.2.6. Rest of Europe
8.3. Middle East and Africa
8.3.1. Kingdom of Saudi Arabia
8.3.2. United Arab Emirates
8.3.3. Qatar
8.3.4. South Africa
8.3.5. Egypt
8.3.6. Morocco
8.3.7. Nigeria
8.3.8. Rest of Middle-East and Africa
8.4. North America
8.4.1. Canada
8.4.2. Mexico
8.4.3. United States
8.5. Latin America
8.5.1. Argentina
8.5.2. Brazil
8.5.3. Rest of Latin America
9. Company Profile
9.1. Almac Group
9.1.1. Company details
9.1.2. Financial outlook
9.1.3. Product summary
9.1.4. Recent developments
9.2. Boehringer Ingelheim International GmbH
9.2.1. Company details
9.2.2. Financial outlook
9.2.3. Product summary
9.2.4. Recent developments
9.3. Catalent, Inc.
9.3.1. Company details
9.3.2. Financial outlook
9.3.3. Product summary
9.3.4. Recent developments
9.4. Dr. Reddys Laboratories Ltd.
9.4.1. Company details
9.4.2. Financial outlook
9.4.3. Product summary
9.4.4. Recent developments
9.5. FAMAR Health Care Services
9.5.1. Company details
9.5.2. Financial outlook
9.5.3. Product summary
9.5.4. Recent developments
9.6. Jubilant Pharmova Limited
9.6.1. Company details
9.6.2. Financial outlook
9.6.3. Product summary
9.6.4. Recent developments
9.7. Lonza
9.7.1. Company details
9.7.2. Financial outlook
9.7.3. Product summary
9.7.4. Recent developments
9.8. Recipharm AB
9.8.1. Company details
9.8.2. Financial outlook
9.8.3. Product summary
9.8.4. Recent developments
9.9. Vetter Pharma-Fertigung GmbH & Co. KG
9.9.1. Company details
9.9.2. Financial outlook
9.9.3. Product summary
9.9.4. Recent developments
9.10. Others
10. Conclusion
11. List of Abbreviations
12. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
